Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Iradimed stock

Learn how to easily invest in Iradimed stock.

Iradimed is a medical devices business based in the US. Iradimed shares (IRMD) are listed on the NASDAQ and all prices are listed in US Dollars. Iradimed employs 110 staff and has a trailing 12-month revenue of around $50.3 million.

How to buy Iradimed stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – IRMD. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Iradimed stock price (NASDAQ: IRMD)

Use our graph to track the performance of IRMD stocks over time.

Iradimed shares at a glance

Information last updated 2023-01-25.
Latest market close$36.30
52-week range$26.00 - $55.92
50-day moving average $29.57
200-day moving average $32.73
Wall St. target price$45.50
PE ratio 36.274
Dividend yield $0 (0%)
Earnings per share (TTM) $1.04

Buy Iradimed stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Iradimed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Iradimed price performance over time

Historical closes compared with the close of $36.3 from 2023-01-27

1 week (2023-01-19) N/A
1 month (2022-12-30) 28.31%
3 months (2022-10-28) 21.57%
6 months (2022-07-29) -14.08%
1 year (2022-01-28) -2.42%
2 years (2021-01-29) 46.73%
3 years (2020-01-30) 40.43%
5 years (2018-01-30) 151.21%

Is Iradimed stock undervalued or overvalued?

Valuing Iradimed stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Iradimed's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Iradimed's P/E ratio

Iradimed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Iradimed shares trade at around 36x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Iradimed's PEG ratio

Iradimed's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.46. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Iradimed's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Iradimed's EBITDA

Iradimed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $16.2 million.

The EBITDA is a measure of a Iradimed's overall financial performance and is widely used to measure a its profitability.

Iradimed financials

Revenue TTM $50.3 million
Operating margin TTM 28.79%
Gross profit TTM $32 million
Return on assets TTM 11.46%
Return on equity TTM 18.96%
Profit margin 25.93%
Book value $5.55
Market capitalisation $474.1 million

TTM: trailing 12 months

Iradimed share dividends

91%

Dividend payout ratio: 90.91% of net profits

Recently Iradimed has paid out, on average, around 90.91% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Iradimed shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Iradimed's case, that would currently equate to about $0 per share.

Iradimed's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

Iradimed's most recent dividend payout was on 23 February 2022. The latest dividend was paid out to all shareholders who bought their shares by 15 February 2022 (the "ex-dividend date").

Iradimed share price volatility

Over the last 12 months, Iradimed's shares have ranged in value from as little as $26 up to $55.92. A popular way to gauge a stock's volatility is its "beta".

IRMD.US volatility(beta: 1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Iradimed's is 1.0024. This would suggest that Iradimed's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Iradimed overview

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. .

Frequently asked questions

What percentage of Iradimed is owned by insiders or institutions?
Currently 43.52% of Iradimed shares are held by insiders and 43.858% by institutions.
How many people work for Iradimed?
Latest data suggests 110 work at Iradimed.
When does the fiscal year end for Iradimed?
Iradimed's fiscal year ends in December.
Where is Iradimed based?
Iradimed's address is: 1025 Willa Springs Drive, Winter Springs, FL, United States, 32708
What is Iradimed's ISIN number?
Iradimed's international securities identification number is: US46266A1097
What is Iradimed's CUSIP number?
Iradimed's Committee on Uniform Securities Identification Procedures number is: 46266A109

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site